In addition, the finding that TGF-β inhibition was able to rescue the digit defect (shortening of the middle phalanx) of heterozygous Mir17-92 conditional deletion also supports that the TGF-β deregulation underlies the pathogenesis of Feingold syndrome type 2. The gene discussed is TGFB1; the disease is Feingold syndrome type 2.